Plasma vitamin B6 and risk of myocardial infarction in women

Circulation

Volumn 120, Issue 8, 2009, Pages 649-655

  Page, John H ^a   Ma, Jing ^a   Chiuve, Stephanie E ^a   Stampfer, Meir J ^a,b   Selhub, Jacob ^c   Manson, Joann E ^a,b   Rimm, Eric B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

Biomarkers; Myocardial infarction; Nutrition; Risk factors; Women

Indexed keywords

PYRIDOXAL 5 PHOSPHATE;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; CIGARETTE SMOKING; CORONARY RISK; DIETARY INTAKE; DISEASE ASSOCIATION; FATALITY; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

ADULT; ALCOHOL DRINKING; BODY MASS INDEX; CASE-CONTROL STUDIES; CREATININE; FEMALE; FOLIC ACID; FOOD HABITS; HOMOCYSTEINE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MYOCARDIAL INFARCTION; NUTRITION ASSESSMENT; PROSPECTIVE STUDIES; PYRIDOXAL PHOSPHATE; RISK FACTORS; VITAMIN B 6;

EID: 69549124101     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.809038     Document Type: Article

References (40)

1. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999;19:217-246.
2. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, Hess DL, Davis CE. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1998;98:204-210.
3. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, Hennekens C, Stampfer MJ. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA. 1998;279:359-364. (Pubitemid 28133864)
4. Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA. 2002;288: 973-979.
5. Smith CM, Marks AD, Lieberman M, Marks DB, Marks DB. Marks' Basic Medical Biochemistry : A Clinical Approach. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005.
6. Clayton PT. B6-responsive disorders: a model of vitamin dependency. J Inherit Metab Dis. 2006;29:317-326.
7. Tully DB, Allgood VE, Cidlowski JA. Modulation of steroid receptor-mediated gene expression by vitamin B6. FASEB J. 1994;8:343-349.
8. Salhany JM, Schopfer LM. Pyridoxal 5′-phosphate binds specifically to soluble CD4 protein, the HIV-1 receptor: implications for AIDS therapy. J Biol Chem. 1993;268:7643-7645.
9. Abraham GE, Schwartz UD, Lubran MM. Effect of vitamin B-6 on plasma and red blood cell magnesium levels in premenopausal women. Ann Clin Lab Sci. 1981;11:333-336.
10. Chasan-Taber L, Selhub J, Rosenberg IH, Malinow MR, Terry P, Tishler PV, Willett W, Hennekens CH, Stampfer MJ. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr. 1996;15:136-143.
11. Friso S, Girelli D, Martinelli N, Olivieri O, Lotto V, Bozzini C, Pizzolo F, Faccini G, Beltrame F, Corrocher R. Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr. 2004;79:992-998.
12. Vermaak WJ, Barnard HC, Potgieter GM, Marx JD. Plasma pyridoxal-5′-phosphate levels in myocardial infarction. S Afr Med J. 1986;70: 195-196.
13. Leklem JE, Hollenbeck CB. Acute ingestion of glucose decreases plasma pyridoxal 5′-phosphate and total vitamin B-6 concentration. Am J Clin Nutr. 1990;51:832-836.
14. Vermaak WJ, Barnard HC, Van Dalen EM, Potgieter GM, Van Jaarsveld H, Myburgh SJ. Compartmentalization of pyridoxal-5′-phosphate during the acute phase of myocardial infarction. Klin Wochenschr. 1988;66: 428-433.
15. Willett W. Nutritional Epidemiology. 2nd ed. New York, NY: Oxford University Press; 1998.
16. Willett WC, Sampson L, Browne ML, Stampfer MJ, Rosner B, Hen-nekens CH, Speizer FE. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol. 1988;127:188-199.
17. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquan-titative food frequency questionnaire. Am J Epidemiol. 1985;122:51-65.
18. Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, Longcope C, Speizer FE. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995;87:1297-1302.
19. Wu K, Helzlsouer KJ, Comstock GW, Hoffman SC, Nadeau MR, Selhub J. A prospective study on folate, B12, and pyridoxal 5′-phosphate (B6) and breast cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:209-217.
20. Camp VM, Chipponi J, Faraj BA. Radioenzymatic assay for direct measurement of plasma pyridoxal 5′-phosphate. Clin Chem. 1983;29: 642-644.
21. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
22. Salazar DE, Corcoran GB. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med. 1988;84:1053-1060.
23. Knight EL, Rimm EB, Pai JK, Rexrode KM, Cannuscio CC, Manson JE, Stampfer MJ, Curhan GC. Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol. 2004;15: 1897-1903.
24. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422:43-52.
25. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
26. Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N, Miyauchi K. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem. 1995;41:717-723.
27. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. 4th ed. Malden, Mass: Blackwell Science; 2001.
28. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1998.
29. Lachin JM. Biostatistical Methods: The Assessment of Relative Risks. New York, NY: Wiley; 2000.
30. SAS/GRAPH [computer program]. Cary, NC: SAS Institute Inc; 2004. Version 9.
31. S-PLUS [computer program]. Seattle, Wash: Insightful Corp; 2007. Version 8.
32. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008;299:2027-2036.
33. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578-1588.
34. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567-1577.
35. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565-575.
36. Bor MV, Refsum H, Bisp MR, Bleie O, Schneede J, Nordrehaug JE, Ueland PM, Nygard OK, Nexo E. Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: a randomized placebo-controlled study. Clin Chem. 2003;49:155-161.
37. Lui A, Lumeng L, Aronoff GR, Li TK. Relationship between body store of vitamin B6 and plasma pyridoxal-P clearance: metabolic balance studies in humans. J Lab Clin Med. 1985;106:491-497.
38. Nishmura M, Teschke R. Effect of chronic alcohol consumption on the activities of liver plasma membrane enzymes: gamma-glutamyltransferase, alkaline phosphatase and 5′-nucleotidase. Biochem Pharmacol. 1982;31: 377-381.
39. Fonda ML, Brown SG, Pendleton MW. Concentration of vitamin B6 and activities of enzymes of B6 metabolism in the blood of alcoholic and nonalcoholic men. Alcohol Clin Exp Res. 1989;13:804-809.
40. Bates CJ, Pentieva KD, Prentice A. An appraisal of vitamin B6 status indices and associated confounders, in young people aged 4-18 years and in people aged 65 years and over, in two national British surveys. Public Health Nutr. 1999;2:529-535.